| Název práce v češtině: | Výživa u idiopatických střevních zánětů |
|---|---|
| Název v anglickém jazyce: | Nutrition in inflammatory bowel disease |
| Klíčová slova: | Výživa u Idiopatických střevních zánětů |
| Klíčová slova anglicky: | Nutrition in Inflammatory bowel disease |
| Akademický rok vypsání: | 2024/2025 |
| Typ práce: | bakalářská práce |
| Jazyk práce: | čeština |
| Ústav: | III. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN (11-00530) |
| Vedoucí / školitel: | doc. MUDr. Pavel Kohout, Ph.D. |
| Řešitel: | skrytý - zadáno vedoucím/školitelem |
| Datum přihlášení: | 11.10.2024 |
| Datum zadání: | 11.10.2024 |
| Datum odevzdání elektronické podoby: | 30.06.2025 |
| Oponenti: | MUDr. Petr Tláskal, CSc. |
| Seznam odborné literatury |
[1] Vachala B. Ebersův Staroegyptský lékařský papyrus. 1. vyd. Praha: Academia; 2020. 252 s. [1] Timeline of inflammation [Internet]. stories.uq.edu.au. Available from: [1] Actis GC, Pellicano R, Fagoonee S, Ribaldone DG. History of Inflammatory Bowel Diseases. Journal of Clinical Medicine [Internet]. 2019 Nov 14;8(11). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912289/ [1] Kasper H. Výživa v medicíně a dietetika. 1. vyd. Praha: Grada Publishing; 2015. 592 s. [1] Exposome and Exposomics | NIOSH | CDC [Internet]. archive.cdc.gov. 2022. Available from: https://archive.cdc.gov/www_cdc_gov/niosh/topics/exposome/default.html [1] Caron B, Sailish Honap, Laurent Peyrin-Biroulet. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies. Journal of Crohn s and Colitis. 2024 Oct 1;18(Supplement_2):ii3–15. [1] CSGH [Internet]. Csgh.info. 2025 [cited 2025 Apr 10]. Available from: [1] Lukáš K. Gastroenterologie a hepatologie. 1.vyd. Praha: Grada; 2007. 380 s. [1] Zbořil V. Idiopatické střevní záněty. 1. vyd. Praha: Mladá fronta; 2018. 575 s. [1] Jasmina El Hadad, Schreiner P, Vavricka SR, Greuter T. The Genetics of Inflammatory Bowel Disease. Molecular Diagnosis & Therapy. 2023 Oct 17;28. [1] Database G. IL23R Gene - GeneCards | IL23R Protein | IL23R Antibody [Internet]. Genecards.org. 2024 [cited 2025 Mar 24]. Available from: https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL23R&keywords=IL23R [1] Database G. PTPN2 Gene - GeneCards | PTN2 Protein | PTN2 Antibody [Internet]. Genecards.org. 2024 [cited 2025 Mar 24]. Available from: https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPN2 [1] Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmunity Reviews [Internet]. 2014 Jan;13(1):3–10. Available from: https://www.sciencedirect.com/science/article/pii/S1568997213001043 [1] Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scandinavian Journal of Gastroenterology. 2018 Mar 9;53(4):379–89. [1] de Mattos BRR, Garcia MPG, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, et al. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments. Mediators of Inflammation [Internet]. 2015;2015:1–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539174/ [1] Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. International Journal of Molecular Sciences [Internet]. 2023 Jan 12;24(2):1526. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4539174/ [1] Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, et al. A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn’s Disease. Gastroenterology. 2008 Oct;135(4):1130–41. [1] Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nature Immunology [Internet]. 2014 Jul 1 [cited 2022 Feb 16];15(7):676–86. Available from: https://www.nature.com/articles/ni.2920 [1] Monteleone I, Sarra M, Pallone F, Monteleone G. Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes? Current Molecular Medicine. 2012 May 1;12(5):592–7. [1] Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial Ecology along the Gastrointestinal Tract. Microbes and Environments [Internet]. 2017;32(4):300–13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745014/#idm139786216632464title [1] Shetty SA, Hugenholtz F, Lahti L, Smidt H, de Vos WM. Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiology Reviews [Internet]. 2017 Feb 9 [cited 2021 May 17];41(2):182–99. Available from: https://academic.oup.com/femsre/article/41/2/182/2979411?login=true [1] Manrique P, Bolduc B, Walk ST, van der Oost J, de Vos WM, Young MJ. Healthy human gut phageome. Proceedings of the National Academy of Sciences [Internet]. 2016 Aug 29;113(37):10400–5. Available from: https://www.pnas.org/content/113/37/10400 [1] Rutsch A, Kantsjö JB, Ronchi F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Frontiers in Immunology. 2020 Dec 10;11. [1] Pokusaeva K, Johnson C, Luk B, Uribe G, Fu Y, Oezguen N, et al. GABA-producingBifidobacterium dentiummodulates visceral sensitivity in the intestine. Neurogastroenterology & Motility. 2016 Jul 25;29(1):e12904. [1] created by Dominik Douděra. PHARMANEWS | Odborné konference pro farmaceutické asistenty, lékárníky a sestry [Internet]. Pharmanews.cz. 2016 [cited 2025 Mar 24]. Available from: https://www.pharmanews.cz/clanek/butyrat/ [1] Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019 Jun 13;7(1). [1] Jarmakiewicz-Czaja S, Zielińska M, Sokal A, Filip R. Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. Genes [Internet]. 2022 Dec 16;13(12):2388. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9778199/ [1] ATG16L1 autophagy related 16 like 1 [Homo sapiens (human)] - Gene - NCBI [Internet]. Nih.gov. 2025 [cited 2025 Mar 24]. Available from: https://www.ncbi.nlm.nih.gov/gene?cmd=search&term=55054 [1] UniProt [Internet]. UniProt. 2025 [cited 2025 Mar 24]. Available from: https://www.uniprot.org/uniprotkb/A2AIV8/entry [1] Genenames.org. 2020. Available from: https://www.genenames.org/data/gene-symbol-report/# [1] Sovran B, Planchais J, Jegou S, Straube M, Lamas B, Natividad JM, et al. Enterobacteriaceae are essential for the modulation of colitis severity by fungi. Microbiome. 2018 Sep 1;6(1). [1] Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012 Sep 13;489(7415):220–30. [1] Takagi T, Naito Y, Inoue R, Kashiwagi S, Uchiyama K, Mizushima K, et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. Journal of Clinical Biochemistry and Nutrition. 2018;62(1):100–5. [1] Ge L, Liu S, Li S, Yang J, Hu G, Xu C, et al. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications. Frontiers in Immunology [Internet]. 2022;13:1016578. Available from: https://pubmed.ncbi.nlm.nih.gov/36275694/ [1] Bernabeu P, Buades N, Alonso M, Van-der Hofstadt C, Gutiérrez A, Sempere L, et al. P529 Impact of stress in inflammatory bowel disease. Effect of a group psychological intervention program. Journal of Crohn’s and Colitis. 2017 Jan 26;11(suppl_1):S349–9. [1] Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmunity Reviews. 2004 Jul;3(5):394–400. [1] Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology [Internet]. 2002 Nov 1 [cited 2020 Feb 24];123(5):1527–42. Available from: https://www.ncbi.nlm.nih.gov/pubmed/12404228/ [1] Přehledové články [Internet]. Available from: https://www.internimedicina.cz/pdfs/int/2009/01/03.pdf [1] Johns Hopkins Medicine. Inflammatory Bowel Disease (IBD) [Internet]. www.hopkinsmedicine.org. 2024. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/inflammatory-bowel-disease [1] Veauthier B, Hornecker JR. Crohn’s Disease: Diagnosis and Management. American Family Physician. 2018 Dec 1;98(11):661–9. [1] Seung Min Hong, Dong Hoon Baek. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond. Diagnostics [Internet]. 2024 Jun 28;14(13):1384–4. Available from: https://www.mdpi.com/2075-4418/14/13/1384 [1] Gecse KB, Vermeire S. Differential diagnosis of inflammatory bowel disease: imitations and complications. The Lancet Gastroenterology & Hepatology. 2018 Sep;3(9):644–53. [1] Dujsíková H. Farmakoterapie idiopatických střevních zánětů. Interní medicína pro praxi [Internet]. 2024 [cited 2025 Apr 8];21(1):28–31. Available from: https://www.internimedicina.cz/artkey/int-201901-0006_farmakoterapie_idiopatickych_strevnich_zanetu.php [1] Sandborn WJ, Regula J, Feagan BG, Belousova E, Jojic N, Lukas M, et al. Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis. Gastroenterology [Internet]. 2009 Dec 1 [cited 2021 Feb 19];137(6):1934-1943.e3. Available from: https://www.gastrojournal.org/article/S0016-5085%2809%2901570-4/fulltext [1] Patel M, Cripps S. Inflammatory Bowel disease: Treatment and Management [Internet]. The Pharmaceutical Journal. 2021. Available from: https://pharmaceutical-journal.com/article/ld/inflammatory-bowel-disease-treatment-and-management [1] Stoppino LP, Della Valle N, Rizzi S, Cleopazzo E, Centola A, Iamele D, et al. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers. BMC Medical Imaging. 2016 May 5;16(1). [1] Hirai F, Uda A, Ota M, Takemura Y, Tanaka K, Iwakiri R. Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan. Digestion [Internet]. 2023;104(2):109–20. Available from: https://pubmed.ncbi.nlm.nih.gov/36450239/ [1] Jean Fréd́eric Colombel, Ungaro RC, Sands BE, Siegel CA, Wolf DC, Valentine JF, et al. Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER). Clinical Gastroenterology and Hepatology. 2023 Sep 1; [1] Nakashima J, Preuss CV. Mesalamine (USAN) [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551714/ [1] Petra. Tofacitinib. Interní medicína pro praxi [Internet]. 2024 [cited 2025 Apr 3];21(5):292–4. Available from: https://www.internimedicina.cz/artkey/int-201905-0008_tofacitinib.php?back=%2Fsearch.php%3Fquery%3DTofacitinib%26sfrom%3D0%26spage%3D30 [1] Rudra Narayan Subudhi, Neelam Poonia, Singh D, Arora V. Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations. Natural Products and Bioprospecting. 2024 Jul 30;14(1). [1] Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative Colitis and Crohn’s Disease Have the Same Burden and Goals for Treatment. Clinical Gastroenterology and Hepatology. 2019 Jul;18(1). [1] Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut microbiome variation. Science. 2016 Apr 28;352(6285):560–4. [1] Guo A, Ludvigsson J, Brantsæter AL, Klingberg S, Östensson M, Størdal K, et al. Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts. Gut [Internet]. 2024 Jan 3 [cited 2024 Jan 31]; Available from: https://gut.bmj.com/content/early/2024/01/02/gutjnl-2023-330971 [1] Park J, Kato K, Murakami H, Koji Hosomi, Kumpei Tanisawa, Takashi Nakagata, et al. Comprehensive analysis of gut microbiota of a healthy population and covariates affecting microbial variation in two large Japanese cohorts. BMC Microbiology. 2021 May 20;21(1). [1] Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. Journal of Allergy and Clinical Immunology [Internet]. 2020 Jan 1;145(1):16–27. Available from: https://www.jacionline.org/article/S0091-6749(19)31486-1/fulltext [1] Kim H, Kim YJ, Jeong HY, Kim JY, Choi EK, Chae SW, et al. A standardized extract of the fruit of Hovenia dulcis alleviated alcohol-induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. Journal of Ethnopharmacology. 2017 Sep;209:167–74. [1] van de Loo AJAE, Mackus M, Kwon O, Krishnakumar IM, Garssen J, Kraneveld AD, et al. The Inflammatory Response to Alcohol Consumption and Its Role in the Pathology of Alcohol Hangover. Journal of Clinical Medicine. 2020 Jul 2;9(7):2081. [1] Knihy - Nakladatelství Academia [Internet]. Academia.cz. 2025 [cited 2025 Apr 25]. Available from: https://www.academia.cz/knihy?id=3156 [1] Bevilacqua A, Speranza B, Racioppo A, Santillo A, Albenzio M, Derossi A, et al. Ultra-Processed Food and Gut Microbiota: Do Additives Affect Eubiosis? A Narrative Review. Nutrients [Internet]. 2024 Dec 24 [cited 2025 Jan 10];17(1):2. Available from: https://www.mdpi.com/2072-6643/17/1/2 [1] Abar L, Steele EM, Lee SK, Kahle L, Moore SC, Watts E, et al. Identification and validation of poly-metabolite scores for diets high in ultra-processed food: An observational study and post-hoc randomized controlled crossover-feeding trial. PLoS Medicine. 2025 May 20;22(5):e1004560–0. [1] Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ [Internet]. 2021 Jul 15;374:n1554. Available from: https://www.bmj.com/content/374/bmj.n1554.full [1] Cuevas-Sierra A, Milagro FI, Aranaz P, Martínez JA, Riezu-Boj JI. Gut Microbiota Differences According to Ultra-Processed Food Consumption in a Spanish Population. Nutrients. 2021 Aug 6;13(8):2710. [1] Darislav Besedin, Shah R, Brennan C, Panzeri E, Thu T, Rajaraman Eri. Food additives and their implication in inflammatory bowel disease and metabolic syndrome. Clinical Nutrition ESPEN. 2024 Nov 8;64:483–95. [1] Rodriguez-Palacios A, Harding A, Menghini P, Himmelman C, Retuerto M, Nickerson KP, et al. The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn’s Disease–Like Ileitis. Inflammatory Bowel Diseases [Internet]. 2018 Mar 15;24(5):1005–20. Available from: https://academic.oup.com/ibdjournal/article/24/5/1005/4939054 [1] Kwon V, Cai P, Dixon CT, Hamlin V, Spencer CG, Rojas AM, et al. Peripheral NOD-like receptor deficient inflammatory macrophages trigger neutrophil infiltration into the brain disrupting daytime locomotion. Communications Biology [Internet]. 2022 May 16 [cited 2025 Apr 24];5(1). Available from: https://www.nature.com/articles/s42003-022-03410-z.pdf?proof=tWhat [1] Wu S, Yang Z, Liu S, Zhang Q, Zhang S, Zhu S. Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study. Clinical gastroenterology and hepatology. 2024 Mar 1;22(7). [1] Ellison ER. A study of diet in Mesopotamia (c.3000 - 600 BC) and associated agricultural techniques and methods of food preparation [Internet]. discovery.ucl.ac.uk. 1978. Available from: https://discovery.ucl.ac.uk/id/eprint/1349279/ [1] Kodama H, Tanaka M, Naito Y, Katayama K, Moriyama M. Japan’s Practical Guidelines for Zinc Deficiency with a Particular Focus on Taste Disorders, Inflammatory Bowel Disease, and Liver Cirrhosis. International Journal of Molecular Sciences. 2020 Apr 22;21(8):2941. [1] Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. International Journal of Molecular Sciences [Internet]. 2020 Dec 31;22(1):362. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795229/pdf/ijms-22-00362.pdf [1] Gubatan J, Chou ND, Nielsen OH, Moss AC. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2019 Oct 24;50(11-12):1146–58. [1] Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients. 2020 Nov 12;12(11):3478. [1] CSGH [Internet]. Csgh.info. 2025 [cited 2025 Jun 17]. Available from: https://www.csgh.info/cs/clanek/karboxymaltoza-zeleza-v-lecbe-deficitu-zeleza-anemie-u-pacientu-s-ibd-11616 [1] Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients. 2020 Mar 29;12(4):944. [1] Nutritional and dietary strategy in the clinical care of inflammatory bowel disease. Journal of the Formosan Medical Association [Internet]. 2019 Oct 14; Available from: https://www.sciencedirect.com/science/article/pii/S0929664619304681 [1] Papada E, Amerikanou C, Forbes A, Kaliora AC. Adherence to Mediterranean Diet in Crohn’s Disease. European Journal of Nutrition [Internet]. 2019 Apr 20;59. Available from: https://link.springer.com/article/10.1007%2Fs00394-019-01972-z [1] Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. Gastroenterology. 2014 Jan;146(1):67-75.e5. [1] Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, et al. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. Journal of Crohn’s and Colitis. 2017 Jun 14;11(12):1420–9. [1] Khan S, Sneha Annie Sebastian, Parmar MP, Nitin Ghadge, Padda I, Keshta AS, et al. Factors influencing the quality of life in inflammatory bowel disease: A comprehensive review. Disease-a-Month. 2023 Dec 1;70(1):101672–2. [1] Scarlata K, Catsos P, Smith J. From a Dietitian’s Perspective, Diets for Irritable Bowel Syndrome Are Not One Size Fits All. Clinical Gastroenterology and Hepatology. 2019 Aug; [1] Meisinger C, Freuer D. Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study. Seminars in Arthritis and Rheumatism. 2022 Aug;55:151992.
|
| Předběžná náplň práce |
| Práce se zabývá vlivem výživy na stav Idiopatických střevních zánětů (Crohnovy choroby a Ulcerózní kolitidy). |
| Předběžná náplň práce v anglickém jazyce |
| This thesis focuses on nutrition in Inflammatory bowel disease (Crohn´s disease and Ulcerative colitis). |